1-palmitoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine

Metabolite details

Identifier

SQGZFCFLUVPOSZ-IVQYLSTHSA-N

InChI Key

SQGZFCFLUVPOSZ-IVQYLSTHSA-N

IUPAC name

(19R)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22λ⁵-phosphapentacosan-19-yl (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

Preferred name

1-palmitoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine

INN name

—

Synonym

Phophatidylethanolamine(16:0/22:4n6)

ChEBI

CHEBI:84549

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_Palmitate
• G1_Ctrl_vs_G2_Ab
• BSA_Control_vs_AA